The World Health Organization's (WHO) recently released 2023 global TB report has shed light on the challenges and progress in the fight against tuberculosis (TB) worldwide. In 2022, a staggering 7.5 million people were diagnosed with TB, marking the highest number since records began in 1995.
According to a comprehensive report by Fox News Digital, this medication has proven to be a game-changer, demonstrating a substantial reduction in the five-year risk of recurrent cancer by an impressive 73% and decreasing the risk of death by an equally remarkable 51%.
Sanjay Kandasamy, the first paediatric liver transplant recipient in India, has come full circle. Now a 25-year-old doctor practising in Kanchipuram, he serves as a ray of hope and awareness for organ donation.
The US Food and Drug Administration (FDA) has granted approval for Zepbound (tirzepatide), a novel medication for chronic weight management in adults facing obesity or related conditions. Developed by pharmaceutical giant Eli Lilly.